Two portfolio companies of ROSNANO are named Technology Pioneers 2014

Portfolio companies of ROSNANO Selecta Biosciences and BIND Therapeutics specialize at leading investigations and developments in the sphere of nanomedicine. Key element of cooperation between ROSNANO and Selecta and BIND is transfer of leading technologies into Russia. In November, 2012 Selecta Biosciences became the first foreign project company of ROSNANO in pharmacy section, which opened scientific-investigation center in Russia – it located in Khimki on the territory of high technologies center “KhimRar”. In March, 2013 workers of “Selecta (RUS)” confirmed technologies transfer tSVP from the Boston laboratory into Russia, synthesizing the first platform of antinicotinic vaccine nano-particles.
“It is a honor for us to become one of Technology Pioneers, and we are grateful to the Global Economy Forum for such recognition of technology leadership and innovativeness of our developments”, - noted Dmitry Ovchinnikov, deputy of director general of the company “Selecta (RUS)”. – Rank of a Technology Pioneer motivates us on further development. Opening if investigation center gives Selecta Biosciences an opportunity to develop by heightened rates with purpose of keeping this status of one of leaders in global nanomedicine in future, simultaneously contributing transfer of technologies into Russia, integration of Russian science into global, and developing biomedicine in the country”.
From the moment of technology Pioneers establishment in 2000, more than 550 innovation companies became its owners, which base on all five continents and offering the most various branches. A list of laureates of Technology Pioneers 2014 entered 36 companies. Awarding will be conducted September, 11-13 at a special meeting of laureates in Dalian, China.
Похожее
The portfolio Company of ROSNANO “BIND Therapeutics” has conducted IPO at NAS
Rosnano will present products of portfolio companies at “Open innovations”
Две портфельные компании РОСНАНО названы Technology Pioneers 2014
BIND, Rusnano portfolio company, completes IPO at NASDAQ
Компания-партнер "Роснано" получила премию за инновации в фармацевтике